YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer

PD-1 and PD-L1 antibodies have brought about extraordinary clinical benefits for cancer patients, and their indications are expanding incessantly. Currently, most PD-1/PD-L1 agents are administered intravenously, which may be uncomfortable for some cancer patients. Herein, we develop a novel oral-de...

詳細記述

保存先:
書誌詳細
主要な著者: Fangfang Lai (著者), Ming Ji (著者), Lei Huang (著者), Yunchen Wang (著者), Nina Xue (著者), Tingting Du (著者), Kai Dong (著者), Xiaoqing Yao (著者), Jing Jin (著者), Zhiqiang Feng (著者), Xiaoguang Chen (著者)
フォーマット: 図書
出版事項: Elsevier, 2022-06-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

インターネット

Connect to this object online.

3rd Floor Main Library

予約・返却請求 3rd Floor Main Library
請求記号: A1234.567
所蔵 1 利用可